Abstract
The extent of existing federal authority over commercial applications of the recombinant DNA method is an important question, since this biotechnology increasingly becomes the subject of industrialization. This article examines the statutory authority of three agencies—the Food and Drug Administration, the Occupational Safety and Health Administration, and the Environmental Protection Agency—to regulate the recombinant DNA method both in the workplace and as a new method of manufacture of chemicals, particularly drugs. These agencies have extensive powers to regulate the manufacture and distribution of products made by the recombinant DNA technique under the Federal Food, Drug, and Cosmetic Act, the Occupational Safety and Health Act, and the Toxic Substances Control Act.
- Received July 14, 1982.
- Accepted August 9, 1982.
- Copyright © Parenteral Drug Association. All rights reserved.
PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.
If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing.
Full issue PDFs are for PDA members only.
Note to pda.org users
The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.